NCT01609166View on ClinicalTrials.gov

Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

September 30, 2012

Study Completion Date

December 31, 2012

Conditions
Hand-foot Syndrome
Interventions
DRUG

Allopurinol

Allopurinol 3% cream application in one side of the body, twice a day for 6 months

DRUG

Placebo

Placebo cream application in the other side of the body, twice a day for 6 months

Trial Locations (1)

08025

Hospital de la Santa Creu i Sant Pau, Barcelona

All Listed Sponsors
lead

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

OTHER

NCT01609166 - Effectiveness Allopurinol Topical Agent Prevention Capecitabine-induced Hand-foot Syndrome | Biotech Hunter | Biotech Hunter